期刊
MOLECULAR CARCINOGENESIS
卷 55, 期 3, 页码 292-299出版社
WILEY-BLACKWELL
DOI: 10.1002/mc.22278
关键词
breast cancer; autophagy; gene expression; survival analysis
资金
- National Natural Science Foundation of China [81201822, 31300943, 81372213]
- Research Fund for the Doctoral Program of Higher Education of China [20112307110011]
- Postdoctoral Science Foundation of China [2012M511509]
- Postdoctoral Foundation of Heilongjiang Province [LBH-Z11083]
Autophagy is a process that degrades intracellular constituents, such as long-lived or damaged proteins and organelles, to buffer metabolic stress under starvation conditions. Deregulation of autophagy is involved in the progression of cancer. However, the predictive value of autophagy for breast cancer prognosis remains unclear. First, based on gene expression profiling, we found that autophagy genes were implicated in breast cancer. Then, using the Cox proportional hazard regression model, we detected autophagy prognostic signature for breast cancer in a training dataset. We identified a set of eight autophagy genes (BCL2, BIRC5, EIF4EBP1, ERO1L, FOS, GAPDH, ITPR1 and VEGFA) that were significantly associated with overall survival in breast cancer. The eight autophagy genes were assigned as a autophagy-related prognostic signature for breast cancer. Based on the autophagy-related signature, the training dataset GSE21653 could be classified into high-risk and low-risk subgroups with significantly different survival times (HR=2.72, 95% CI=(1.91, 3.87); P=1.37x10(-5)). Inactivation of autophagy was associated with shortened survival of breast cancer patients. The prognostic value of the autophagy-related signature was confirmed in the testing dataset GSE3494 (HR=2.12, 95% CI=(1.48, 3.03); P=1.65x10(-3)) and GSE7390 (HR=1.76, 95% CI=(1.22, 2.54); P=9.95x10(-4)). Further analysis revealed that the prognostic value of the autophagy signature was independent of known clinical prognostic factors, including age, tumor size, grade, estrogen receptor status, progesterone receptor status, ERBB2 status, lymph node status and TP53 mutation status. Finally, we demonstrated that the autophagy signature could also predict distant metastasis-free survival for breast cancer. (c) 2015 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据